Showing 2756 results
-
Press release /Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is currently in…
-
Biography /
-
Media Library / -
Media Library / -
Media Library / -
Media Library /
Pagination
- ‹ Previous page
- 1
- …
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- …
- 276
- › Next page